Kianoush Motesharei's most recent trade in NeuBase Therapeutics Inc was a trade of 250,000 Employee stock option (right to buy) done . Disclosure was reported to the exchange on May 24, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NeuBase Therapeutics Inc | Kianoush Motesharei | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 250,000 | 250,000 | - | - | Employee stock option (right to buy) |